“Long-term monitoring and treatment of these patients is urgent and important,” it concluded.
The research, which has been published in the European Respiratory JournalExternal link, was conducted as part of the Swiss national Covid-19 lung study by the Bern University Hospital in collaboration with the University of Bern.
A statement released by the hospitalExternal link said that since the summer of 2020 various studies around the world had reported symptoms and side effects of what is known as long-Covid. The observational Swiss study aims to document the medium and long-term trajectory of the disease with focus on the lungs.
“The study provides important baseline data for the clinical care of long-term Covid-19 patients worldwide,” the statement said.
Reduction of oxygen uptake
Using data from nine Swiss hospitals, researchers looked at 113 cases of Covid-19, of which 66 had had it severely and 47 had had a mild to critical course. It found that while the second group was almost completely well after several months, the first group were struggling.
“Even four months after the infection severe Covid-19 causes a one fifth reduction in oxygen uptake capacity compared to a healthy person,” the statement said.
“It is important that the suffering of these people is taken seriously even after they have recovered from the infection,” pneumologist Manuela Funke-ChambourExternal link, who initiated the study, told the Swiss news agency Keystone SDA-ATS.
Most of the more strongly affected patients belonged to one of the Covid-19 risk groups: older people, the overweight or people suffering from high blood pressure.
“This emphasizes the important of prompting prevention among these groups, for example by vaccinating,” she added. There had however also been severe cases needing longer treatment among non-risk patients, the researcher explained.
At present, it is not known whether the lung damage is permanent, and researchers will continue to follow the progress of patients with persistent symptoms or pulmonary lesions over the coming year.
The study, conducted by the University of Geneva and the University Hospitals of Geneva, followed nearly 700 people who had tested positive for Covid-19 but who had not needed to go to hospital. Six weeks after diagnosis, 33% of then reported that they still suffered from fatigue, loss of smell or taste, shortness of breath or a cough.
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Swiss plan 1,600 extra trains for Eurovision, Women’s EURO 2025 and other events
This content was published on
Swiss Federal Railways is planning to operate 1,600 additional trains to transport passengers to special events in 2025, such as the UEFA Women's EURO 2025 and the Eurovision Song Contest.
Swiss study: higher prices for cheese with protected geographical indication
This content was published on
Indications of geographical origin play a central role in the cheese trade, a study by the Agroscope research centre shows.
Swiss campaigners launch another ‘responsible business initiative’
This content was published on
A coalition has launched a new "responsible business initiative", urging the government to ensure that Swiss-based multinationals and their subsidiaries abroad respect human rights and protect the environment.
Swiss court suspends Geneva plan to ban single-use plastics
This content was published on
A Geneva court has suspended a ban on the sale of single-use plastics in the city, which was due to be introduced on January 1. This follows an appeal by Swiss retailers to the Federal Court.
Swiss cable car firms and hotels report positive winter so far
This content was published on
The Swiss cable car association and Switzerland Tourism have reported higher visitor numbers at winter resorts over the Christmas and New Year period compared to 2023/24.
UBS expects Swiss National Bank to record CHF80bn profit in 2024
This content was published on
The Swiss National Bank (SNB) is expected to make a net profit of CHF80 billion ($88.4 billion) in 2024, according to UBS.
This content was published on
Consumer prices fell last year in Switzerland, new figures show. Higher rents and electricity prices were partially offset by lower prices for gas and prescription drugs.
This content was published on
New data from the Federal Office of Public Health (FOPH) shows that flu cases doubled in Switzerland between mid and late December.
Swiss bank Julius Bär sells its Brazilian operation
This content was published on
Swiss private bank Julius Bär has signed an agreement to sell its operation in Brazil for 615 million reais, or CHF91 million ($100.7 million).
Historian claims Swiss banks may hold further Second World War secrets
This content was published on
Bank archives could still hold secrets about Swiss actions during the Second World War and should be re-examined, especially those of UBS, says Marc Perrenoud, a historian who worked on the Bergier Commission.
Artificial intelligence helps bring about record-fast vaccines
This content was published on
The development of two highly effective Covid-19 vaccines in record time was made possible thanks to artificial intelligence.
Swiss logistics firm to distribute Moderna Covid vaccine globally
This content was published on
Swiss company Kühne+Nagel has concluded a distribution and storage agreement for the Covid-19 vaccine developed by the American biotech firm.
Swiss researchers create artificial lung to study Covid-19 blood clots
This content was published on
Scientists in Lausanne have created an artificial lung to better understand how the new coronavirus causes blood clots in certain patients.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.